102例慢性丙型肝炎患者血清免疫球蛋白和补体水平变化*

doi:10.3969/j.issn.1672-5069.2015.05.023

Abstract

He Taojun，Yang Laizhi，Wu Runxiang，et al.. Changes of serum immunoglobulins and complement C3 and C4 in 102 patients with chronic hepatitis C[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(5): 538-539.

[1] Agmon-Levin N，Ram M，Barzilai O，et al． Prevalence of hepatitis C serum antibody in autoimmune diseases. J Autoimmun，2009，32（2）: 261-266．
[1] 朱庆峰，左维泽，刘佩芝，等.抗病毒治疗对Ib型慢性丙肝患者PBMC IL-10、IL-12水平变化影响的研究.临床和实验医学杂志，2013，1（12）：11-14.
[2] 干泳华.干扰素治疗慢性丙肝所致间质性肺炎的临床特征分析.中国医学创新，2013，10（30）：103-104.
[3] 刘贵臣.慢性丙肝患者血清谷丙转氨酶水平、丙肝病毒RNA定量对干扰素疗效的影响.中国医药科学，2012，2（9）：171-174.
[4] 张红梅，张小玉，李红艳，等.慢性丙型肝炎患者病毒基因分型及HCV RNA相关性研究.检验医学与临床，2014，11（24）：3395-3397.
[5] Mohd Hanafiah K，Groeger J，Flaxman AD，et al. Global epidemiology of hepatitis C virus infection:New estimates of age-specific antibody to HCV seroprevalence. Hepatology，2013，57（4）:1333-1342.
[6] 钱福初，邹伟华，秦基取，等.基因芯片对慢性丙型肝炎患者血清病毒基因分型的应用研究.中国预防医学杂志，2012，13（7）：530-532.
[7] 肖作汉，孟冈，王立志. 慢性丙型肝炎患者感染病毒基因型对抗病毒治疗应答的影响. 实用肝脏病杂志，2014，17（2）：188-189.
[8] 周友乾，尹凤鸣，冯经华. 丙型肝炎病毒载量与基因型和抗病毒疗效的关系研究. 实用肝脏病杂志，2011，14（5）：340-343.
[9] 袁园，陈兆军，潘峰. 丙型肝炎病毒核心抗原检测在慢性丙肝感染中的临床应用. 中国卫生检验杂志，2014，24（19）：2793-2795.
[10] 谢尧，李明慧.慢性丙型肝炎标准抗病毒治疗的新时代. 实用肝脏病杂志，2012，15（5）：384-386.
[11] 常静霞，张怡青，王洁.慢性丙型肝炎患者病毒基因分型与血清HCV RNA水平的关系探讨.实用肝脏病杂志，2012，15（4）：321-323.
[12] 张效本，阮秀花，田葱.142例慢性丙型肝炎患者血清HCV-cag和HCV RNA检测结果分析.实用肝脏病杂志，2013，16（4）：358-359.
[13] Ortar k Z，Toyran A，Sen S，et al. Evaluation of serum IgG， IgA and IgM levels as indicators of hepatic fibrosis in patients with chronic hepatitis C infection. Mikrobiyol Bul，2011，45（2）:296-305.

[1]	Pan Meimin, Li Wenjuan, Jiang Fangqing, et al.. Changes of serum IL-17A,fibroblast growth factor and IL-7 levels in patients with hepatitis C virus infection [J]. Journal of Practical Hepatology, 2019, 22(6): 840-843.
[2]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[3]	Deng Haohui, Li Xiaoqiang, Gao Hongbo, et al. Comparison of HCV genotypes in patients with HIV/HCV co-infection and HCV mono-infection in Guangzhou [J]. Journal of Practical Hepatology, 2019, 22(5): 656-659.
[4]	Liu Li，Li Junyi，Du Yingrong. Efficacy and safety of sofosbuvir/daclatasvir in the treatment of patients with chronic hepatitis C and hepatitis C cirrhosis:An real-world study [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 361-364.
[5]	Zhou Yanyi, Yang Can. Efficacy of tripterygium glycosides combined with magnesium isoglycyrrhizinate in treatment of patients with autoimmune hepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 365-368.
[6]	Jiang Yi, Liu Bing. Comparison of clinical features and histopathological activity index between patients with chronic hepatitis B and chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 188-191.
[7]	Wu Jing, Dong Baoji, Wu Chao. Comparison of PD-1 receptor on peripheral blood follicular helper T lymphocyte surface in chronic hepatitis C patients with low and high serum viral loads [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 192-195.
[8]	Wu Yaping, Zhou Bingqing, Jiang Peili. Risk factors of severe hepatic fibrosis in patients with chronic hepatitis C with previous paid blood donation [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 196-199.
[9]	Yang Zhenjie, Li Hongtao, Wang Jian, Li Xia, Chen Yuan. Efficacy of combination of pegylated interferon-α-2a and ribavirin in treatment of patients with compensated hepatitis C cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 232-235.
[10]	Hou Chunyang, Ma Yumei, Li Fangzhi.. Clinical efficacy of peg-IFNα and ribavirin combination in treating patients with chronic hepatitis C and genotype one and six infection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 53-56.
[11]	Zhao Peng, Wang Lei.. Comparison of therapeutic efficacy of pegylated interferon-α in treatment of patients with different hepatitis C viral genotype infection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 57-60.
[12]	Xu Xi, Dang Yinli, Wu Shuo.. Construction and expression of recombinant eukaryotic expression vector of HCV infection related interferon λ4 [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 833-836.
[13]	Xu Guorong, Chai Lili.. Efficacy of combination inoculation of hepatitis B vaccine and hepatitis B immunoglobulin on blocking mother-to-child transmission of hepatitis B virus infection in newborn with serum HBsAg/HBeAg-positive mothers [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 851-854.
[14]	Ji Xiaoqin, Gong Jian.. Clinical features and antiviral treatment of elderly patients with chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 995-998.
[15]	Zhou Sisi, Shen Youxiu, Li Juan, et al.. Changes of peripheral blood Th17 and Treg cells and their related serum cytokines in patients with chronic hepatitis C and liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 689-692.

Changes of serum immunoglobulins and complement C3 and C4 in 102 patients with chronic hepatitis C

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments